Pharmacy benefit-manager Express Scripts drops one hepatitis C drug in favor of a cheaper new one.

Prescription-drug benefit company makes an exclusive deal with drug-maker.

Pharmaceutical company AbbVie says it will reconsider a merger in light of new tax regulations.